Q2 2021 13F Holders as of 30 Jun 2021
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share
-
Shares outstanding
-
22.3M
-
Number of holders
-
104
-
Total 13F shares, excl. options
-
7.2M
-
Shares change
-
-80.7K
-
Total reported value, excl. options
-
$252M
-
Value change
-
-$2.87M
-
Put/Call ratio
-
3.76
-
Number of buys
-
46
-
Number of sells
-
-45
-
Price
-
$35.05
Significant Holders of ANI PHARMACEUTICALS INC - Common Stock, par value $0.0001 per share (ANIP) as of Q2 2021
114 filings reported holding ANIP - ANI PHARMACEUTICALS INC - Common Stock, par value $0.0001 per share as of Q2 2021.
ANI PHARMACEUTICALS INC - Common Stock, par value $0.0001 per share (ANIP) has 104 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 7.2M shares
of 22.3M outstanding shares and own 32.34% of the company stock.
Largest 10 shareholders include BlackRock Inc. (1.55M shares), VANGUARD GROUP INC (619K shares), DIMENSIONAL FUND ADVISORS LP (439K shares), STATE STREET CORP (400K shares), INVESTMENT COUNSELORS OF MARYLAND LLC (384K shares), THOMPSON SIEGEL & WALMSLEY LLC (380K shares), GOLDMAN SACHS GROUP INC (362K shares), AMERIPRISE FINANCIAL INC (275K shares), FEDERATED HERMES, INC. (263K shares), and FIRST WILSHIRE SECURITIES MANAGEMENT INC (239K shares).
This table shows the top 104 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.